- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06465771
Feasibility of a Youth-led NCD Risk Reduction Initiative in Selected Schools of Slums in Karachi, Pakistan: a Mixed-methods, pre-and Post-intervention Study
June 13, 2024 updated by: Sabahat Naz, Aga Khan University
The study will occur in ten selected schools within Azam Basti and Mehmoodabad, organized into five sequential phases.
Phase I involves identifying NCD modifiable risk factors among younger peers (Classes 5 and 6 students) using structured diaries.
Phase II includes qualitative interviews with youth (Classes 9 and 10 students), parents, and stakeholders to discuss intervention material and delivery.
Phase III comprises a one-day workshop to co-create an intervention.
Phase IV involves three-day training for youth to understand and deliver the intervention to their peers.
Finally, Phase V assesses the intervention's feasibility using a pre-and post-test design approach.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sabahat Naz
- Phone Number: 03362293099
- Email: sabahat.naz1@aku.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Both government and private schools
- Schools that have classes 1 to 10 in one boundary
- Schools who agree to take part in the qualitative interviews
- Schools that permit to engage youth, their parents, and younger peers in the study for ten months
- For youth: Students of classes 9 and 10 (aged 14 to 16 years)
- For younger peers: Students of classes 5 and 6 (9 to 12 years)
- Students who provide written informed assent followed by parental consent
- Parents of youth and other stakeholders, including head teachers, schoolteachers, and canteen staff who provide written informed consent
Exclusion Criteria:
- Schools currently enrolled in any NCD-related intervention program or any similar program during the last six months
- For youth: Having any severe or chronic medical condition or disability that restricts active participation of students in the intervention co-creation and delivery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Youth-led NCD risk reduction initiative
Students of grades 5 and 6 will receive NCD risk reduction intervention from youth (students of grades 9 and 10).
The shared risk factors will include unhealthy diet, physical activity, and tobacco use.
The NCDs will cover diabetes, cardiovascular disease, hypertension, and cancers.
|
With the help of Youth (students of grades 9 and 10), their parents and other stakeholders, including teachers, headteachers, and canteen staff through qualitative interviews, we will develop an intervention focuses on NCD risk reduction among younger peers (students of grades 5 and 6).
A nutritionist will train the youth on how to deliver the intervention among their younger peers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The compliance of delivering the intervention in schools using a fidelity checklist
Time Frame: Three months
|
Once the intervention will be finalized, a fidelity checklist will be developed and used to assess adherence to the intervention delivery.
It will be reported as if the intervention is delivered completely, partially, or incomplete based on each component of the intervention
|
Three months
|
The recruitment and attrition rates for schools and children
Time Frame: Ten months
|
The recruitment and attrition rates will be assessed by reporting the frequencies and percentages of schools and children (youth and younger peer) enrolled and retained in the study.
|
Ten months
|
The rate for completing the structured diaries for diet, physical activity, and tobacco use at pre-and post-intervention assessments
Time Frame: Ten months
|
The frequencies and percentages of children completing the structured diaries for diet, physical activity, and tobacco use at pre-and post-intervention assessments will be reported.
|
Ten months
|
The change in the frequency and percentages of risk factors, including unhealthy diet, physical inactivity, and tobacco use at post-intervention compared to the baseline using a structured diary
Time Frame: Ten months
|
The change in the frequency and percentages of risk factors, including unhealthy diet, physical inactivity, and tobacco use at post-intervention compared to the baseline will be reported.
The information will be collected through structured diaries at baseline and after the intervention is delivered.
The students will complete the diary for four days before and after the intervention.
|
Ten months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2024
Primary Completion (Estimated)
August 31, 2025
Study Completion (Estimated)
August 31, 2025
Study Registration Dates
First Submitted
May 27, 2024
First Submitted That Met QC Criteria
June 13, 2024
First Posted (Estimated)
June 19, 2024
Study Record Updates
Last Update Posted (Estimated)
June 19, 2024
Last Update Submitted That Met QC Criteria
June 13, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9763
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinActive, not recruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Youth-led NCD risk reduction intervention
-
Rutgers, The State University of New JerseyNational Center for Advancing Translational Sciences (NCATS)CompletedHypertension | Health Knowledge, Attitudes, Practice | Adolescent BehaviorUnited States
-
University of PennsylvaniaNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHuman Immunodeficiency Virus (HIV) | Sexually Transmitted Disease (STD)United States
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingMaternal Cytomegalovirus Infections | Cytomegalovirus CongenitalUnited States
-
Emory UniversityAmerican University of ArmeniaCompletedHIV Infections | HIV PreventionArmenia
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedHIV Infections | Sexually Transmitted DiseasesUnited States
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted
-
Temple UniversityColumbia University; Centers for Disease Control and Prevention; Nova Southeastern...Unknown
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedSexually Transmitted Disease (STD) | Human Immunodeficiency Virus Infection (HIV)United States
-
National Institute of Allergy and Infectious Diseases...Completed